Bioavailability of inhaled or ingested PFOA adsorbed to house dust

Environ Sci Pollut Res Int. 2022 Nov;29(52):78698-78710. doi: 10.1007/s11356-022-20829-3. Epub 2022 Jun 14.

Abstract

Indoor environments may impact human health due to chemical pollutants in the indoor air and house dust. This study aimed at comparing the bioavailability and distribution of PFOA following both an inhalation and an oral exposure to PFOA coated house dust in rats. In addition, extractable organofluorine (EOF) was measured in different tissue samples to assess any potential influence of other organofluorine compounds in the experimental house dust. Blood samples were collected at sequential time points after exposure and at the time of termination; the lungs, liver, and kidney were collected for quantification of PFOA and EOF. The concentration of PFOA in plasma increased rapidly in both exposure groups attaining a Cmax at 3 h post exposure. The Cmax following inhalation was four times higher compared to oral exposures. At 48 h post exposure, the levels of PFOA in the plasma, liver, and kidney were twice as high from inhalation exposures. This shows that PFOA is readily bioavailable and has a rapid systemic distribution following an inhalation or oral exposure to house dust coated with PFOA. The proportion of PFOA to EOF corresponded to 65-71% and 74-87% in plasma and tissues, respectively. The mass balance between EOF and target PFOA indicates that there might be other unknown PFAS precursor and/or fluorinated compounds that co-existed in the house dust sample that can have accumulated in rats.

Keywords: Adsorption; Airways; Gastro intestinal (GI); Household dust; Ingestion; PFAS; Perfluorooctanoic acid.

MeSH terms

  • Animals
  • Biological Availability
  • Dust / analysis
  • Environmental Pollutants* / analysis
  • Fluorocarbons* / analysis
  • Humans
  • Rats

Substances

  • Dust
  • Fluorocarbons
  • Environmental Pollutants